venBio Global Strategic GP II, L.P.'s Net Worth
$142 Million
Who is venBio Global Strategic GP II, L.P.?
venBio Global Strategic GP II, L.P. has an estimated net worth of $142 Million. This is based on reported shares across multiple companies, which include Checkmate Pharmaceuticals, Inc., ALX ONCOLOGY HOLDINGS INC, Akero Therapeutics, Inc., and IMPEL NEUROPHARMA INC.
SEC CIK
venBio Global Strategic GP II, L.P.'s CIK is 0001729409
Past Insider Trading and Trends
2020 was venBio Global Strategic GP II, L.P.'s most active year for acquiring shares with 7 total transactions. venBio Global Strategic GP II, L.P.'s most active month to acquire stocks was the month of June. 2020 was venBio Global Strategic GP II, L.P.'s most active year for disposing of shares, totalling 32 transactions. venBio Global Strategic GP II, L.P.'s most active month to dispose stocks was the month of March. 2020 saw venBio Global Strategic GP II, L.P. paying a total of $19,207,000.00 for 11,646,518 shares, this is the most they've acquired in one year. In 2020 venBio Global Strategic GP II, L.P. cashed out on 32,925,100 shares for a total of $20,743,395.94, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Checkmate Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -5.75% | -131.65K |
$10.45 | -$1,375,564.42 | 2.16M |
May 13 - May 16
| |||
Form 4
| -6.57% | -160.90K |
$10.39 | -$1,671,823.84 | 2.29M |
May 10 - May 12
| |||
Form 4
| -3.42% | -86.68K |
$10.37 | -$898,920.56 | 2.45M |
May 5 - May 9
| |||
Form 4
| -9.65% | -270.68K |
$10.38 | -$2,809,332.35 | 2.54M |
May 2 - May 4
| |||
Form 4
| -6.34% | -190.03K |
$10.38 | -$1,972,578.78 | 2.81M |
Apr 27 - Apr 29
| |||
Form 4
| -4.15% | -129.78K |
$10.39 | -$1,347,796.50 | 3M |
Apr 22 - Apr 26
| |||
Form 4
| -14.91% | -547.73K |
$10.41 | -$5,700,491.17 | 3.13M |
Apr 19 - Apr 21
| |||
Form 4
|
∞
| 3.67M |
$15.00 |
—
| 3.67M |
Aug 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Akero Therapeutics, Inc. (AKRO) Snapshot price: $17.835
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -3.70% | -116.47K |
$34.40 | -$4,006,536.85 | 3.03M |
Jul 1 - Jul 6
| |||
Form 4
| -1.44% | -45.95K |
$23.76 | -$1,091,607.66 | 3.15M |
Mar 4 - Mar 6
| |||
Form 4
| -0.68% | -21.80K |
$22.63 | -$493,310.23 | 3.2M |
Feb 28 - Mar 3
| |||
Form 4
| -0.18% | -5.90K |
$22.80 | -$134,635.10 | 3.23M |
Feb 25 - Feb 27
| |||
Form 4
| -0.15% | -10.03K |
$27.07 | -$271,399.19 | 6.46M |
Feb 10 - Feb 12
| |||
Form 4
| -0.19% | -6.10K |
$27.03 | -$164,954.76 | 3.23M |
Feb 6
| |||
Form 4
| -2.48% | -82.34K |
$25.77 | -$2,121,726.32 | 3.24M |
Feb 4 - Feb 5
| |||
Form 4
| -12.95% | -494.00K |
$20.23 | -$9,993,620.00 | 3.32M |
Jan 13
| |||
Form 4
| -0.41% | -15.68K |
$19.86 | -$311,354.63 | 3.82M |
Jan 8
| |||
Form 4
| -1.88% | -73.22K |
$19.86 | -$1,454,529.98 | 3.83M |
Jan 6 - Jan 7
| |||
Form 4
| -0.90% | -35.50K |
$19.71 | -$699,721.20 | 3.91M |
Jan 2 - Jan 3
| |||
Form 4
| -0.36% | -14.32K |
$23.96 | -$343,258.90 | 3.94M |
Dec 31
| |||
Form 4
|
∞
| 3.95M |
$16.00 |
—
| 3.95M |
Jun 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
IMPEL NEUROPHARMA INC (IMPL) Snapshot price: $0.05
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.76M |
$15.00 |
—
| 2.76M |
Apr 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ALX ONCOLOGY HOLDINGS INC (ALXO) Snapshot price: $15.02
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +584.38% | 7.97M |
$19.00 |
—
| 9.34M |
Jul 16 - Jul 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||